Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.

HIV-1 directionality of HIV-1 transmission molecular epidemiology phylogenetic transmission

Journal

HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392

Informations de publication

Date de publication:
05 2021
Historique:
revised: 17 10 2020
received: 31 01 2020
accepted: 21 10 2020
pubmed: 29 12 2020
medline: 15 3 2022
entrez: 28 12 2020
Statut: ppublish

Résumé

Understanding the drivers of HIV-1 transmission is of importance for curbing the ongoing epidemic. Phylogenetic methods based on single viral sequences allow us to assess whether two individuals are part of the same viral outbreak, but cannot on their own assess who potentially transmitted the virus. We developed and assessed a molecular epidemiology method with the main aim to screen cohort studies for and to characterize individuals who are 'potential HIV-1 transmitters', in order to understand the drivers of HIV-1 transmission. We developed and validated a molecular epidemiology approach using longitudinally sampled viral Sanger sequences to characterize potential HIV-1 transmitters in the Swiss HIV Cohort Study. Our method was able to identify 279 potential HIV-1 transmitters and allowed us to determine the main epidemiological and virological drivers of transmission. We found that the directionality of transmission was consistent with infection times for 72.9% of 85 potential HIV-1 transmissions with accurate infection date estimates. Being a potential HIV-1 transmitter was associated with risk factors including viral load [adjusted odds ratio Our results indicate that longitudinally sampled Sanger sequences do not provide sufficient information to identify transmitters with high certainty at the individual level, but that they allow the drivers of transmission at the population level to be characterized.

Identifiants

pubmed: 33368946
doi: 10.1111/hiv.13030
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

346-359

Informations de copyright

© 2020 British HIV Association.

Références

UNAIDS. Global HIV & AIDS statistics - 2018 fact sheet [Internet]. 2018 [cited 2018 Oct 11]. Available from: http://www.unaids.org/en/resources/fact-sheet
Klingemann HKH. Drug treatment in Switzerland: harm reduction, decentralization and community response. Addiction 1996; 91: 723-736.
Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes seropositives ne souffrant d’aucune autre MST et suivant un traitment antiretrovial efficace ne transmettent pas le VIH pas voie sexuelle Schweiz Arzteztg 2008; 89: 165-169.
Günthard HF, Calvez V, Paredes R et al. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel. Clin Infect Dis 2018; 68: 177-187.
Turk T, Bachmann N, Kadelka C et al. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. eLife 2017; 6. Available from: https://elifesciences.org/articles/28721
Marzel A, Kouyos RD, Reinschmidt S et al. Dietary Patterns and Physical Activity Correlate With Total Cholesterol Independently of Lipid-Lowering Drugs and Antiretroviral Therapy in Aging People Living With Human Immunodeficiency Virus. Open Forum Infect Dis 2018;5. Available from: https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofy067/4953064
Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Engl J Med 2011; 365: 493-505.
Rodger AJ, Cambiano V, Bruun T et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 2016; 316: 171.
Gueler A, Moser A, Calmy A et al. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS. 2017; 31: 427-436. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-900000000-97629
Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
Kouyos RD, von Wyl V, Yerly S et al. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in switzerland. J Infect Dis 2010; 201: 1488-1497.
Beyrer C, Sullivan P, Sanchez J et al. The increase in global HIV epidemics in MSM. AIDS 2013; 27: 2665-2678.
Sullivan PS, Carballo-Diéguez A, Coates T et al. Successes and challenges of HIV prevention in men who have sex with men. Lancet 2012; 380: 388-399.
Marzel A, Shilaih M, Yang W-L et al. HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the swiss HIV cohort study. Clin Infect Dis 2016; 62: 115-122.
Wittkop L, Günthard HF, de Wolf F et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 2011; 11: 363-371.
Alizon S, von Wyl V, Stadler T et al. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog. 2010; 6: e1001123.
Shirreff G, Alizon S, Cori A et al. How effectively can HIV phylogenies be used to measure heritability? Evol Med Public Health 2013; 2013: 209-224.
Bachmann N, Turk T, Marzel A et al. Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup. Retrovirology 2017; 14. Available from: http://retrovirology.biomedcentral.com/articles/10.1186/s12977-017-0356-3
Faria NR, Rambaut A, Suchard MA et al. The early spread and epidemic ignition of HIV-1 in human populations. Science 2014; 346: 56-61.
Hassan AS, Pybus OG, Sanders EJ, Albert J, Esbjörnsson J. Defining HIV-1 transmission clusters based on sequence data. AIDS 2017; 31: 1211-1222.
Volz EM, Frost SDW. Inferring the source of transmission with phylogenetic data. PLoS Comput Biol 2013; 9: 1003397.
Bbosa N, Ssemwanga D, Ssekagiri A et al. Phylogenetic and demographic characterization of directed HIV-1 transmission using deep sequences from high-risk and general population cohorts/groups in Uganda. Viruses 2020; 12: 331.
Kouyos RD, Kadelka C, Huber M et al. Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature 2018; 561: 406-410.
Kusejko K, Kadelka C, Marzel A et al. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study. Virus Evol. 2018;4. Available from: https://academic.oup.com/ve/article/doi/10.1093/ve/vey024/5101427
Dennis AM, Herbeck JT, Brown AL et al. Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest? J Acquir Immune Defic Syndr 1999; 2014: 181-195.
Smith DM, Richman DD, Little SJ. HIV Superinfection. J Infect Dis 2005; 192: 438-444.
The Swiss HIV Cohort Study, Schoeni-Affolter F, Ledergerber B et al. Cohort Profile: The Swiss HIV Cohort Study. Int J Epidemiol. 2010;39:1179-1189.
von Wyl V, Kouyos RD, Yerly S et al. The role of migration and domestic transmission in the spread of HIV-1 Non-B Subtypes in Switzerland. J Infect Dis 2011; 204: 1095-1103.
Ragonnet-Cronin ML, Shilaih M, Günthard HF et al. A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland. Sci Rep 2016; 6. Available from: http://www.nature.com/articles/srep32251
BLAST [Internet]. [cited 2018 Nov 1]. Available from: https://blast.ncbi.nlm.nih.gov/Blast.cgi
Los Alamos.HIV Database [Internet]. [cited 2018 Dec 20]. Available from: www.hiv.lanl.gov/
Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32: 1792-1797.
Stanford University. HIV drug resistance database [Internet]. [cited 2018 Nov 1]. Available from: http://hivdb.stanford.edu/
International Antiviral Society-USA [Internet]. [cited 2018 Nov 1]. Available from: https://www.iasusa.org/
Capella-Gutierrez S, Silla-Martinez JM, Gabaldon T. trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics 2009; 25: 1972-1973.
Felsenstein J. Phylogenies and the Comparative Method. Am Nat 1985; 125: 1-15.
Si Quang L, Gascuel O, Lartillot N. Empirical profile mixture models for phylogenetic reconstruction. Bioinformatics 2008; 24: 2317-2323.
Rusert P, Kadelka C, Ebner H et al. Determinants of HIV-1 broadly neutralizing antibody induction. Nat Med 2016; 22: 1260-1267.
R Core Team. A language and environment for statistical computing. R Foundation. for Statistical Computing, Vienna, Austria. [Internet]. 2018 [cited 2019 Nov 1]. Available from: https://www.R-project.org/
Ripley B, tree: Classification and Regression Trees. R package version 1.0-39. [Internet]. 2018 [cited 2019 Nov 1]. Available from: https://cran.r-project.org/web/packages/tree/tree.pdf
Paradis E, Claude J, Strimmer K. APE: Analyses of phylogenetics and evolution in R language. Bioinformatics 2004; 20: 289-290.
Revell LJ. phytools: an R package for phylogenetic comparative biology (and other things): phytools: R package. Methods Ecol Evol 2012; 3: 217-223.
Gordon M. forestplot: Advanced Forest Plot Using “grid” Graphics. R package version 1.8. [Internet]. 2017 [cited 2018 Nov 19]. Available from: https://cran.r-project.org/web/packages/forestplot/forestplot.pdf
Garbuszus JM, Jeworutzki S.readstata13: Import “Stata” Data. Files. R package version 0.9.0. [Internet]. 2017 [cited 2019 Oct 1]. Available from: https://CRAN.R-project.org/package=readstata13
Wickham H. stringr: Simple, Consistent Wrappers for Common String Operations. R package version 1.3.0. [Internet]. 2018 [cited 2018 Nov 11]. Available from: https://CRAN.R-project.org/package=stringr
Meyer D, Zeileis A, Hornik K.VCD: Visualizing Categorical Data. R package version 1.4-4. [Internet]. [cited 2018 Nov 11]. Available from: https://cran.r-project.org/web/packages/vcd/vcd.pdf
Harrell FERMS Jr. Regression Modeling Strategies. R package version 5.1-2. [Internet]. 2018 [cited 2019 Oct 1]. Available from: https://CRAN.R-project.org/package=rms
Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. Am Psychol 1993; 48: 1035-1045.
Mayer KH, Venkatesh KK. Interactions of HIV, Other Sexually Transmitted Diseases, and Genital Tract Inflammation Facilitating Local Pathogen Transmission and Acquisition: HIV, STD & INFLAMMATION. Am J Reprod Immunol 2011; 65: 308-316.
Bachmann N, Kusejko K, Nguyen H, Roger D, et al. Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men. Clinical Infectious Diseases. 2020; ciaa411. http://dx.doi.org/10.1093/cid/ciaa411
Arts EJ, Hazuda DJ. HIV-1 Antiretroviral Drug Therapy. Cold Spring Harb Perspect Med 2012; 2: a007161.
Romero-Severson EO, Bulla I, Leitner T. Phylogenetically resolving epidemiologic linkage. Proc Natl Acad Sci USA 2016; 113: 2690-2695.
Leitner T, Romero-Severson E. Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants. Nat Microbiol 2018; 3: 983-988.
Wymant C, Hall M, Ratmann O et al. PHYLOSCANNER: Inferring Transmission from Within- and Between-Host Pathogen Genetic Diversity. Mol Biol Evol 2018; 35: 719-733.
Günthard HF, Kouyos R. Can Directionality of HIV Transmission be Predicted by Next-Generation Sequencing Data? J Infect Dis 2018; 220: 1393-1395. Available from https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiy737/5259182
Ou C-Y, Ciesielski CA, Myers G et al. Molecular Epidemiology of HIV Transmission in a Dental Practice. Science 1992; 256: 1165-1171.
Metzker ML, Mindell DP, Liu X-M, Ptak RG, Gibbs RA, Hillis DM. Molecular evidence of HIV-1 transmission in a criminal case. Proc Natl Acad Sci 2002; 99: 14292-14297.
Bernard E, Azad Y, Vandamme A, Weait M, Geretti A. HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission. HIV Med 2007; 8: 382-387.

Auteurs

M L Reichmuth (ML)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

S E Chaudron (SE)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

N Bachmann (N)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

H Nguyen (H)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

J Böni (J)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

K J Metzner (KJ)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

M Perreau (M)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

T Klimkait (T)

Department of Biomedicine, University of Basel, Basel, Switzerland.

S Yerly (S)

Laboratory of Virology, Geneva University Hospital, Geneva, Switzerland.

H H Hirsch (HH)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.

C Hauser (C)

Department of Infectious Diseases, Bern University Hospital, Bern, Switzerland.

A Ramette (A)

Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

P Vernazza (P)

Division of Infectious Diseases, Cantonal Hospital St Gallen, St Gallen, Switzerland.

M Cavassini (M)

Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

E Bernasconi (E)

Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.

H F Günthard (HF)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

K Kusejko (K)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

R D Kouyos (RD)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH